HCW Biologics Inc.
HCWB
$6.02
$0.132.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.93M | -2.20M | -3.37M | -3.90M | -15.28M |
| Total Depreciation and Amortization | 291.90K | 419.00K | 682.50K | 128.40K | 129.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.60M | 425.60K | 292.10K | 232.40K | 239.80K |
| Change in Net Operating Assets | -45.00K | -2.16M | -436.20K | 614.90K | 10.05M |
| Cash from Operations | -3.28M | -3.51M | -2.83M | -2.93M | -4.86M |
| Capital Expenditure | -- | -- | -113.40K | -37.10K | 18.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -113.40K | -37.10K | 18.60K |
| Total Debt Issued | 150.00K | -- | 375.00K | 2.83M | 1.95M |
| Total Debt Repaid | -30.90K | -32.50K | -31.00K | -29.60K | -29.10K |
| Issuance of Common Stock | 5.30M | 1.70K | 6.92M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -802.60K | -22.30K | -638.00K | -- | -- |
| Cash from Financing | 4.61M | -53.10K | 6.62M | 2.80M | 1.92M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.33M | -3.57M | 3.68M | -163.10K | -2.92M |